EUVIMEDEUVIMED entdecken
Crossref

Serum metabolomic profiling of breast cancer and its clinicopathological associations

Harpreet Kaur, Shreya Singh Kashyap, Surmeet Kaur, Rajiv Devgan, Sumitoj Singh, Sukhraj Kaur, Jatinder Singh, Manpreet Kaur

The Journal of Steroid Biochemistry and Molecular Biology · 2027-02 · 266 · 107145

DOI: 10.1016/j.jsbmb.2026.107145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2027-02. Verfasst von Harpreet Kaur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab 143005, India. Electronic address: harpreethuman.rsh@gndu.ac.in. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is one of the most prevalent and fatal malignancies affecting women worldwide, yet effective biomarkers for its early detection remain limited. This study aimed to identify differential metabolites associated with breast cancer susceptibility and progression. Serum metabolomic profiling was performed in breast cancer patients and healthy controls using gas chromatography-mass spectrometry. Suitable statistical analyses were performed using MetaboAnalyst 6.0, and the diagnostic potential of metabolites was assessed using the receiver operating characteristic curve. A total of 239 metabolites were identified, of which 25 showed statistically significant differences between study groups. Pathway analysis revealed alterations in the serine, glycine, and threonine pathway, along with glycerolipid and pentose phosphate pathways. Clinicopathological analysis revealed increased metabolic abnormalities with disease progression and hormonal status. Glyceric acid, 4-hydroxybutyric acid, and Hydrazinecarboxylic acid ethyl ester were consistently altered across all parameters, whereas the majority changed selectively. Notably, this is the first metabolomic study in a north-west Indian cohort to identify specific clinicopathological relationships in breast cancer risk and progression. Among differential metabolites, glyceric acid was identified as a key metabolite, demonstrating fair diagnostic potential (AUC=0.721) and consistent dysregulation across tumour grade, TNM staging, and hormonal receptor status. Additionally, butanenitrile appeared as a novel stage-specific biomarker candidate, while propyl formate demonstrated significant TNM stage- and hormonal status-associated alterations. Overall, the serum metabolomic profile of breast cancer patients differed markedly from that of healthy controls. The identified differential metabolites and their associations with clinicopathological features highlight their potential relevance to breast cancer and warrant further validation in larger, independent cohorts.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerDiagnostic potentialGlyceric acidHormonal statusTNM stage

Autor:innen und Institutionen

  • Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab 143005, India. Electronic address: harpreethuman.rsh@gndu.ac.in.
  • Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab 143005, India. Electronic address: shreyasingh.human@gndu.ac.in.
  • Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab 143005, India. Electronic address: surmeet.human@gndu.ac.in.
  • Department of Radiation Oncology, GND Hospital, Government Medical College, Amritsar, Punjab 143001, India. Electronic address: drrajivdevgan@yahoo.co.in.
  • Department of Surgery, GND Hospital, Government Medical College, Amritsar, Punjab 143001, India. Electronic address: sumitoj@rediffmail.com.
  • Department of Microbiology, Guru Nanak Dev University, Amritsar, Punjab 143005, India. Electronic address: sukhraj.micro@gndu.ac.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Kaur, H., Kashyap, S. S., Kaur, S., Devgan, R., Singh, S., Kaur, S., Singh, J., & Kaur, M. (2027). Serum metabolomic profiling of breast cancer and its clinicopathological associations. The Journal of Steroid Biochemistry and Molecular Biology, 266, 107145. https://doi.org/10.1016/j.jsbmb.2026.107145

Vancouver

Kaur H, Kashyap SS, Kaur S, Devgan R, Singh S, Kaur S, et al. Serum metabolomic profiling of breast cancer and its clinicopathological associations. The Journal of Steroid Biochemistry and Molecular Biology. 2027;266:107145. doi:10.1016/j.jsbmb.2026.107145

BibTeX
@article{Kaur2027,
  author = {Kaur, Harpreet and Kashyap, Shreya Singh and Kaur, Surmeet and Devgan, Rajiv and Singh, Sumitoj and Kaur, Sukhraj and Singh, Jatinder and Kaur, Manpreet},
  title = {Serum metabolomic profiling of breast cancer and its clinicopathological associations},
  journal = {The Journal of Steroid Biochemistry and Molecular Biology},
  year = {2027},
  volume = {266},
  pages = {107145},
  doi = {10.1016/j.jsbmb.2026.107145}
}
Kostenlos starten →